| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $23.6M | +649.5% |
| Cost of Revenue | $2.1M | +256.1% |
| R&D Expense | $108.6M | +4.3% |
| SG&A Expense | $92.0M | +34.4% |
| Operating Income | -$179.2M | -5.3% |
| Interest Expense | $5.2M | — |
| Net Income | -$181.1M | -160.2% |
| EPS (Basic) | -$3.47 | -147.9% |
| EPS (Diluted) | -$3.47 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $127.7M | +115.5% |
| Short-term Investments | $205.6M | -12.7% |
| Accounts Receivable | $6.2M | +507.2% |
| Inventory | $2.9M | +2527.9% |
| Current Assets | $354.2M | +14.9% |
| Total Assets | $382.5M | +16.1% |
| Current Liabilities | $39.8M | -8.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$173.4M | -18.8% |
| Capital Expenditures | $281K | -35.3% |
| Investing Cash Flow | $28.0M | +145.1% |
| Financing Cash Flow | $213.8M | +28.4% |
| Free Cash Flow | -$173.7M | -18.6% |
| -147.9% |
| Total Liabilities |
| $118.2M |
| +160.6% |
| Stockholders' Equity | $264.3M | -7.0% |